42 articles for J Lai
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.

University of Arizona
Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.

University of Arizona
Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.

University of Arizona
Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.

University of Arizona
Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics.

Vrije Universiteit Brussel
Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities.

University of Arizona
Biological active analogues of the opioid peptide biphalin: mixeda/ß(3)-peptides.

D'Annunzio University of Chieti���Pescara
Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation.

3-V Biosciences
cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: part 2.

D'Annunzio University of Chieti���Pescara
The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.

D'Annunzio University of Chieti���Pescara
Design and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain.

University of Arizona
Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists.

University of Arizona
Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists.

University of Arizona
Synthesis and biological evaluation of new biphalin analogues with non-hydrazine linkers.

University of Arizona
Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands.

University of Arizona
Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.

Vrije Universiteit Brussel
Discovery of a potent and efficacious peptide derivative ford/µ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.

University of Arizona
Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2.

Sapienza University of Rome
Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.

University of Arizona
Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues.

Sapienza University of Rome
The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety.

University of Arizona
Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain.

University of Arizona
Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue.

Sapienza University of Rome
The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.

University of Arizona
Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors.

University of Arizona
Partial retro-inverso, retro, and inverso modifications of hydrazide linked bifunctional peptides for opioid and cholecystokinin (CCK) receptors.

University of Arizona
Synthesis and biological activity of the first cyclic biphalin analogues.

University of Arizona
Mapping the kinase domain of Janus Kinase 3.

Aventis Pharmaceuticals
Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.

University of Arizona
Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities.

University of Arizona
Chiral Effect of a Phe Residue in Position 3 of the Dmt

University of Arizona
Effect of anchoring 4-anilidopiperidines to opioid peptides.

University of Arizona
Combination therapy with glutaminase inhibitors

Calithera Biosciences
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors

Incyte
Immunomodulators

Bristol-Myers Squibb
Pyrrolobenzodiazepines and conjugates thereof

Mersana Therapeutics
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication

Viiv Healthcare UK (NO.5)
Triazolopyridines and triazolopyrazines as LSD1 inhibitors

Incyte
Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.

Smithkline Beecham Pharmaceuticals
Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies.

Universita Degli Studi Di Firenze
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.

University of Nottingham
3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

Smithkline Beecham Pharmaceuticals